[Immunoregulative effects of XXXX and @entity11057 ].

@entity19 @entity11057 @entity1139 @entity13693 @entity56 @entity9880
Physiological factors involved in immunity and tissue repair with regulate homeostasis, a physiological function of the connective tissue, are as yet unidentified. We earlier detected the granulation-promoting action of @entity9880 , and reported on the acceleration of tissue repair in experimental as well as clinical studies. In that study, immunoregulatory effects of @entity9880 and @entity11057 were examined by the plaque-forming cell (PFC) count and delayed @entity56 (DHR). The PFC value increased in @entity19 pretreated with these agents. In these @entity19 , PFC reaction to 2 X 10(7) SRBC was enhanced but that to 1 X 10(9) SRBC was suppressed. The agents also suppressed excess immunoreaction in immature @entity19 but increased weakened immunoreaction in aged animals. Furthermore, the agents had the optimal doses for the enhancement of both PFC reaction to 1 X 10(8) SRBC and DHR to 1% @entity13693 . They also induced recovery of immunofunction suppressed by the administration of @entity1139 . @entity9880 and @entity11057 exerts immunoregulatory effects by activating both T and B cells. Our observations indicated that the agents not only promote tissue repair but also help maintain homeostasis and accelerate spontaneous healing.
